Research Article

Effects of Sitagliptin Treatment on Dysmetabolism, Inflammation, and Oxidative Stress in an Animal Model of Type 2 Diabetes (ZDF Rat)

Table 1

Body weight, lipid profile and blood pressure in the control and diabetic ZDF rats at the initial and final time (6 weeks of vehicle or sitagliptin treatment).

Initial Time (20 wks)Final Time (26 wks)

Control ZDF (+/+)Diabetic ZDF (fa/fa)Control ZDF (+/+)Diabetic ZDF (fa/fa)

Groups(n=16)(n=16) Vehicle (n=8)Vehicle (n=8)Sitagliptin (n=8)

BW (g)406.70±6.83388.10±8.87445.70±8.16354.40±8.85aaa380.00±14.46
Total-c (mg/dl)77.50±1.50155.50±3.50aaa93.00±2.96193.00±9.79aaa193.10±4.62
TGs (mg/dl)115.00±11.00374.50±4.95a154.00±19.14400.20±27.00aaa237.10±22.54bbb
Systolic (mmHg)115.50±0.83125.20±0.27116.00±2.52127.80±1.23a101.60±0.78bbb
Diastolic (mmHg)100.98±0.8291.46±0.83103.50±1.94112.70±3.9894.86±0.70bbb
Mean (mmHg)104.25±0.25108.20±1.42104.30±4.25117.40±3.04a96.86±0.51bbb
Pulse P (mmHg)14.52±0.9833.74±0.3714.00±4.1615.09±3.086.71±1.11b

BW, body weight; P, pressure; SITA, sitagliptin; Total-c, Total-cholesterol; TGs, triglycerides; ZDF, Zucker diabetic fatty. Values are means ± SEM of n rats. Comparisons between groups: a - ZDF (fa/fa) versus ZDF (+/+) and b - sitagliptin versus vehicle; P<.05, P<.01 and P<.001 for one, two or three letters, respectively.